Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complement System01:27

Complement System

12.2K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
12.2K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

15.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

10.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.0K
Coagulation01:09

Coagulation

11.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.8K
Coagulation01:06

Coagulation

1.6K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Tokusanai et al. <i>Prunus mume</i> Extract Inhibits SARS-CoV-2 and Influenza Virus Infection In Vitro by Directly Targeting Viral Particles. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 8487.

International journal of molecular sciences·2026
Same author

<i>Prunus mume</i> Extract Inhibits SARS-CoV-2 and Influenza Virus Infection In Vitro by Directly Targeting Viral Particles.

International journal of molecular sciences·2025
Same author

Targeted Elimination of Influenza Virus and Infected Cells with Near-Infrared Antiviral Photoimmunotherapy (NIR-AVPIT).

Pharmaceutics·2025
Same author

Association of low ficolin-2 concentration in cord serum with respiratory distress syndrome in preterm newborns.

Frontiers in immunology·2023
Same author

Association of the <i>FCN2</i> Gene Promoter Region Polymorphisms with Very Low Birthweight in Preterm Neonates.

International journal of molecular sciences·2022
Same author

Thrombin cleaves recombinant soluble thrombomodulin into a lectin-like domain fragment and a fragment with protein C-activating cofactor activity.

Bioscience trends·2022

Related Experiment Video

Updated: Mar 20, 2026

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

9.0K

Dual modulating functions of thrombomodulin in the alternative complement pathway.

Koichiro Tateishi1, Mio Imaoka, Misao Matsushita

  • 1Department of Applied Biochemistry, Tokai University.

Bioscience Trends
|May 24, 2016
PubMed
Summary

Thrombomodulin (TM) regulates the complement system. This study shows recombinant TM (rTM) enhances both activation and inactivation in the alternative pathway, revealing dual functions.

More Related Videos

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
18:30

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Published on: February 13, 2013

22.5K
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

7.4K

Related Experiment Videos

Last Updated: Mar 20, 2026

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

9.0K
RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
18:30

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Published on: February 13, 2013

22.5K
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

7.4K

Area of Science:

  • Immunology
  • Biochemistry
  • Vascular Biology

Background:

  • Thrombomodulin (TM) is a protein on endothelial cells with anticoagulant and anti-inflammatory roles.
  • Emerging research indicates TM modulates the complement system, an immune pathway involved in pathogen defense and inflammation.
  • Previous studies suggested TM negatively regulates the complement alternative pathway by enhancing C3b degradation.

Purpose of the Study:

  • To investigate the effects of recombinant human soluble TM (rTM) on the complement alternative pathway.
  • To confirm and further elucidate TM's role in complement regulation.

Main Methods:

  • Utilized recombinant human soluble TM (rTM) in biochemical assays.
  • Assessed the degradation of complement component C3b using SDS-PAGE.
  • Analyzed the cleavage of C3 during alternative pathway activation.

Main Results:

  • rTM enhanced the degradation of C3b into iC3b by factors I and H, confirming its inhibitory role.
  • rTM was also found to enhance the cleavage of C3 into C3b, indicating an activating role.
  • These findings demonstrate a dual function of TM in the complement alternative pathway.

Conclusions:

  • Thrombomodulin exhibits both activating and inactivating functions within the complement alternative pathway.
  • rTM serves as a valuable tool for studying TM's complex role in complement regulation.
  • Understanding TM's dual role is crucial for its therapeutic potential in immune and inflammatory conditions.